Liu Quan

Associate Professor,Doctoral Supervisor



进入个人主页 返回到师资列表


Quan Liu, M.D., Ph.D., is an associate professor in the School of Medicine at SUSTech as well as a junior attending surgeon. Dr. Liu achieved his Medical Degree from Harbin Medical University (HMU) in 2002. He received his surgical training at the Second Affiliated Hospital of HMU from late 2002 through 2008 and specialized in cardiothoracic surgery. Dr. Liu moved forward for his Ph.D. degree and spent over 8 years (from 2009 to 2017) at the University of Pittsburgh. He studied transplantation immunobiology, inflammation regulation, and immunobiology of IL-33 and regulatory T cells (Treg) in the Thomas E. Starzl Transplantation Institute at the University of Pittsburgh with Drs. Heth Turnquist and Adrian Morelli.


1. Alloantigen presentation

2. Immunobiology of IL-33, Treg and ILC2 in settings of transplantation, inflammation regulation and tumor

3. Immunotherapy


09.1997-06.2002, Clinical medicine, Undergraduate college, Haerbin Medical University

09.2002-06.2005, Surgery, Master, Haerbin Medical University

09.2008-12.2011, Surgery, Doctor, Haerbin Medical University

02.2009-08.2009, Clinical heart/lung transplantation observation,  Presbyterian Hospital, University of Pittsburgh Medical Center, USA

12.2009-03.2012, Research fellow, T.E. Starzl Transplantation Institute, University of Pittsburgh, USA

03.2012-02.2014, Postdoctor, T.E. Starzl Transplantation Institute, University of Pittsburgh, USA


2018.08-present, Associate Professor, School of Medicine, Southern University of Science and Technology

03.2014-04.2017,  Research Associate, T.E. Starzl Transplantation Institute, University of Pittsburgh, USA

09.2014-08.2018, Deputy Chief Physician, Cardiovascular Surgery, The Second Affiliated Hospital of Harbin Medical University, China

09.2008-08.2014, Attending Physician, Cardiovascular Surgery, The Second Affiliated Hospital of Harbin Medical University, China

07.2005-08.2008, Resident, Cardiovascular Surgery, The Second Affiliated Hospital of Harbin Medical University, China


  1. Tengfang,Zhongqiang Zhang,Joe G. Bartolacci,Gaelen K. Dwyer,Quan Liu,Lisa R. Mathews,Murugesan Velayutham,Anna S. Roessing,Yoojin C. Lee,Helong Dai,Sruti Shiva, Martin H. Oberbarnscheidt,Jenna L. Dziki,Steven J. Mullet,Stacy G. Wendell,James D. Wilkinson,Steven A. Webber,Michelle Wood-Trageser, Simon C. Watkins,Anthony J. Demetris,George S. Hussey,Stephen F. Badylak and Heth R. Turnquist. Graft IL-33 regulates infiltrating macrophages toprotect against chronic rejection. J Clin Invest. 2020;130(10):5397-5412.

  2. Xiao F, Lin L, Chao Z, Shao C, Chen Z, Wei Z, Lu J, Huang Y, Li L, Liu Q, Liang Y, Tian L. Organic Spherical Nucleic Acids for the Transport of a NIR-II-Emitting Dye Across the Blood-Brain Barrier. Angew Chem Int Ed Engl. 2020. (影响因子12.959,Nature Index journal)

  3. Lin L, Li Y, Liu M, Li Q, Liu Q#, Li R#. The Interleukin-33/ST2 axis promotes glioma mesenchymal transition, stemness and TMZ resistance via JNK activation. Aging. 2020;12:1685-1703.(#共同通讯作者)

  4. Liu Q, Dwyer GK, Zhao Y, Li H, Mathews LR, Chakka AB, Chandran UR, Demetris JA, Alcorn JF, Robinson KM, Ortiz LA, Pitt BR, Thomson AW, Fan MH, Billiar TR, Turnquist HR. IL-33-mediated IL-13 secretion by ST2+ Tregs controls inflammation after lung injury. JCI Insight. 2019;4(6). pii: 123919.

  5. Liu Q, Rojas-Canales DM, Divito SJ, Shufesky WJ, Stolz DB, Erdos G, Sullivan ML, Gibson GA, Watkins SC, Larregina AT, Morelli AE. Donor dendritic cellderived exosomes promote allograft-targeting immune response. J Clin Invest. 2016;126:2805-20. (影响因子12.784,高被引论文,Nature Index journal)

  6. Zhuang Q*, Liu Q*, Divito SJ, Zeng Q, Yatim KM, Hughes AD, Rojas-Canales DM, Nakao A, Shufesky WJ, Williams AL, Humar R, Hoffman RA, Shlomchik WD, Oberbarnscheidt MH, Lakkis FG, Morelli AE. Graft-infiltrating host dendritic cells play a key role in organ transplant rejection. Nat Commun. 2016;7:12623. (*共同第一作者,影响因子12.124,Nature Index journal)

  7. Matta BM, Reichenbach DK, Zhang X, Mathews L, Koehn BH, Dwyer GK, Lott JM, Uhl FM, Pfeifer D, Feser CJ, Smith MJ, Liu Q, Zeiser R, Blazar BR, Turnquist HR. Peri-alloHCT IL-33 administration expands recipient T regulatory cells that protect mice against acute GVHD. Blood. 2016;128:427-39.

  8. Liu Q, Turnquist HR. Controlling the burn and fueling the fire: defining the role for the alarmin interleukin-33 in alloimmunity. Curr Opin Organ Transplant. 2016;21:45-52.

  9. Reichenbach DK, Schwarze V, Matta BM, Tkachev V, Lieberknecht E, Liu Q, Koehn BH1, Pfeifer D, Taylor PA, Prinz G, Dierbach H, Stickel N, Beck Y, Warncke M, Junt T, Schmitt-Graeff A, Nakae S, Follo M, Wertheimer T, Schwab L, Devlin J, Watkins SC, Duyster J, Ferrara JL, Turnquist HR, Zeiser R, Blazar BR. The IL-33/ST2 axis augments effector T-cell responses during acute GVHD. Blood. 2015;125:3183-92.

  10. Xu J, Jiang Y, Wang J, Shi X, Liu Q, Liu Z, Li Y, Scott MJ, Xiao G, Li S, Fan L, Billiar TR, Wilson MA, Fan J.Macrophage endocytosis of high-mobility group box1 triggers pyroptosis. Cell Death Differ. 2014;21:1229-39

  11. Rosborough BR, Raïch-Regué D, Liu Q, Venkataramanan R, Turnquist HR, Thomson AW. Adenosine triphosphate-competitive mTOR inhibitors: a new class of immunosuppressive agents that inhibit allograft rejection. Am J Transplant. 2014;14:2173-80.

  12. Matta BM, Lott JM, Mathews LR, Liu Q, Rosborough BR, Blazar BR, Turnquist HR. IL-33 is an unconventional alarmin that stimulates IL-2 secretion by dendritic cells to selectively expand IL-33R/ST2+ regulatory T cells. J Immunol. 2014;193:4010-20.

  13. Rosborough BR, Mathews LR, Matta BM, Liu Q, Raïch-Regué D, Thomson AW, Turnquist HR.Cutting edge: Flt3 ligand mediates STAT3 independent expansion but STAT3-dependent activation of myeloid-derived suppressor cells. J Immunol. 2014;192:3470-3.

  14. Liu Q, Wang Y, Nakao A, Zhang W, Gorantla V, Zheng XX. Heart allograft tolerance induced and maintained by vascularized hind-limb transplant in rats. Clin Dev Immunol. 2013; 2013:483856.

  15. Du Q, Zhang X, Liu Q, Zhang X, Bartels C, Geller DA. Nitric Oxide Production Upregulates Wnt/β-catenin Signaling By Inhibiting Dickkopf-1. Cancer Res. 2013; 73: 6526-37.(Nature Index journal)

  16. Cheng L, Guo H, Qiao X, Liu Q, Nie J, Li J, Wang J, Jiang K. T cell immunohistochemistry refines lung transplant acute rejection diagnosis and grading. Diagn Pathol. 2013;8:16

  17. Liu Q, Turnquist HR. Implications for Interleukin-33 in solid organ transplantation. Cytokine. 2013;62:183-94.

  18. Turnquist HR, Zhao Z, Rosborough BR, Liu Q, Castellaneta A, Isse K, Wang Z, Lang M, Stolz DB, Zheng XX, Demetris AJ, Liew FY, Wood KJ, Thomson AW. IL-33 expands suppressive CD11b+ Gr-1int and regulatory T cells, including ST2L+ Foxp3+ cells, and mediates regulatory T cell dependent promotion of cardiac allograft survival. J Immunol. 2011; 187: 4598-610.

  19. Divito SJ, Wang Z, Shufesky WJ, Liu Q, Tkacheva OA, Montecalvo A, Erdos G, Larregina AT, Morelli AE. Endogenous dendritic cells mediate the effects of intravenously injected therapeutic immunosuppressive dendritic cells in transplantation. Blood. 2010; 116: 2694-705. 

  20. 刘泉,杨木清,代贺龙.匹兹堡大学Starzl移植研究所学习期间的见闻与思考[J].实用器官移植电子杂志,2018,6(06):477-478.

  21. 刘泉,齐忠权.移植免疫与器官再生的研究进展[J].实用器官移植电子杂志,2018,6(02):90-92+82.

  22. 刁力为,刘大勇,叶明,刘泉,亓峰,孙振东,陈子道,姚志发,吴乃石.热休克预适应对心脏移植供心保护作用的实验研究[J].哈尔滨医科大学学报,2010,44(05):443-446.

  23. 吴乃石,刁力为,刘泉,赵林,亓锋,刘大勇.托拉塞米在重症心脏联合瓣膜置换病人围手术期中的应用[J].中国新药与临床杂志,2006(10):753-755.

  24. 刘泉,吴乃石,孙露,赵林林,刁力为,陈子道,杜金荣.婴儿多发性心脏横纹肌瘤一例[J].中华外科杂志,2006(06):368.

  25. 刘泉,臧旺福,田海.一种新的大鼠同种主动脉瓣异位移植模型[J].中华实验外科杂志,2005(10):114-115.